TGIF1 was shown to enhance the progression of oral squamous cell carcinoma by repressing TGF-β signaling [37], while in breast cancer and lung cancer, TGIF1 can promote tumor growth through activating Wnt/β-catenin signaling independently of TGF-β signaling [30, 31]. Here, TGIF1 is linked to breast carcinoma.